Status:
RECRUITING
Susceptibility to Infectious Diseases in Obesity
Lead Sponsor:
Azienda Ospedaliero Universitaria Maggiore della Carita
Conditions:
Obesity
Type2diabetes
Eligibility:
All Genders
18-65 years
Brief Summary
The role of intestinal microbiota is becoming ever more important in the context of obesity, type II diabetes (T2D), and infectious disorders as represented by the emerging discipline "therapeutic mic...
Detailed Description
Obesity is nowadays a relevant public issue, with more than 650 million people affected worldwide. By definition, obesity is characterized by excessive calorie intake and lowering energy expenditure f...
Eligibility Criteria
Inclusion
- age between 18-65 years
- ability to understand the study protocol
- obesity with BMI between 30-40 kg/m2
- affects by type II diabetes
- presence/absence of chronic infections
- the possibility of equality in the two groups (matched for sex, age, and therapies)
Exclusion
- psychological conditions that reduced the ability the comprehension of the study protocol
- subjects undergoing a diet-therapeutic regimen;
- subjects with the possibility of developing diabetic foot in the successive months
- patients with relapsing infections
- pregnancy
- bariatric surgery
- oncological and hematological pathologies
- Hypogonadism
- severe immunodepression
- vaccination in the last two weeks
- Alcohol or drug abuse
- antibiotic therapy
Key Trial Info
Start Date :
October 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2025
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT05975541
Start Date
October 1 2023
End Date
October 1 2025
Last Update
January 30 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Maggiore della Carità Hospital
Novara, Italy, 28100